The study on the effect of chammomile&lemon balm syrupe in cardiac syndrome x

The study on the effect of Chammomile(Matricaria chamomilla L.)&Lemon balm (Melissa officinalis L.) syrupe on chest pain and quality of life in patient with cardiac syndrome x

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180608040014N1

Enrollment

Registered

2019-01-27

Start date

2019-11-22

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac syndrome x. Angina pectoris, unspecified

Interventions

single group Intervention : chammomile&lemon balm syrupe.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Angina- like chest pain positive exercise stress test angiographically normal epicardial coronary arteries no response to treatments in conventional medicine 4. Recurrent chest pain despite conventional treatment at least 6 months, including a combination of two anti-ischemic (beta-blockers, calcium antagonists) or one anti-ischemic and one alternative( nitrate Statin, ACEI)

Exclusion criteria

Exclusion criteria: sever Valvular heart disease cardiomyopathy coronary spasm LV dysfunction uncontrolled Diabetes mellitus uncontrolled HTN History of myocardial infarction

Design outcomes

Primary

Measure	Time frame
The overall score of pain in the Seattle Angina Questionnaire. Timepoint: at first and end of study(45 days and 90 days after inclusion in the study). Method of measurement: the Seattle Angina questionnare.	—

Secondary

Measure	Time frame
Quality of Life Score in SF36 Quality of Life Questionnaire. Timepoint: at enrolling in the study and 45 days and 90 days after enrolling in the study. Method of measurement: SF36 Quality of Life Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamane noroozi

Tehran University of Medical Sciences

dr.samanenoroozi@gmail.com+98 218897652730

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026